Skip to main content
SI
NYSE Life Sciences

Shoulder Innovations Projects $62M-$65M Revenue for 2026

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$13.88
Mkt Cap
$268.852M
52W Low
$10.92
52W High
$17.94
Market data snapshot near publication time

summarizeSummary

Shoulder Innovations has issued its revenue guidance for fiscal year 2026, projecting sales to be in the range of $62 million to $65 million. This forward-looking statement provides critical financial visibility for investors, allowing them to assess the company's growth trajectory and update their valuation models. For a company of this size, specific revenue guidance is a material data point that helps set market expectations. Traders will be watching for future updates on sales performance and any potential revisions to this guidance throughout the year.

At the time of this announcement, SI was trading at $13.88 on NYSE in the Life Sciences sector, with a market capitalization of approximately $268.9M. The 52-week trading range was $10.92 to $17.94. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed SI - Latest Insights

SI
Apr 27, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
SI
Apr 14, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
7
SI
Mar 10, 2026, 4:20 PM EDT
Filing Type: 10-K
Importance Score:
7
SI
Mar 10, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
SI
Mar 10, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7